Loading company…
Nkure Therapeutics is developing cell, gene and regenerative medicine treatments for cancer and other diseases.
Founded in 2017 and based in Bangalore, India, Nkure Therapeutics is a biopharmaceutical company developing treatments for cancer and other conditions. Its pipeline includes CAR-T therapies for leukemias, multiple myeloma and lymphomas, as well as regenerative medicine and gene treatments. The company’s programs were in clinical research and had not been commercialized as of 2023. In April 2023, it raised pre-series A funding co-led by Endiya, Kotak Investment Advisors and Featherlite, Inc.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in